Human Sex Hormone-Binding Globulin Gene Expression in Transgenic Mice
Marja Jänne,
Harminder K. Deol,
Stephen G. A. Power,
Siu-Pok Yee and
Geoffrey L. Hammond
Departments of Obstetrics and Gynecology, Oncology,
Biochemistry, Pharmacology, and Toxicology Medical Research Council
Group in Fetal and Neonatal Health and Development University of
Western Ontario and London Regional Cancer Center London, Ontario,
Canada N6A 4L6
 |
ABSTRACT
|
---|
The sex hormone-binding globulin gene
(shbg) is expressed in the liver and testis as well as in
several other tissues that play important roles in reproduction.
Expression of shbg in the human liver results in the
production of plasma sex hormone-binding globulin (SHBG), which
regulates the bioavailability of sex steroids in the blood. Although
shbg is not expressed in rodent livers postnatally, it
gives rise to the androgen-binding protein in their testes upon sexual
maturation. Human shbg is also expressed in the testis, but
its products and their function are less well characterized. To study
the expression of human shbg in different tissues and the
consequences of overexpressing this gene in vivo, we have
produced several lines of mice containing
11-kilobase (kb;
shbg11) or 4.3-kb (shbg4) human
shbg genomic fragments that comprise all eight exons
encoding SHBG as well as
6 kb or
0.9 kb of 5'-flanking DNA,
respectively. Northern blots indicated that human shbg
transcripts were most abundant in liver, kidney, and testis of the
shbg11 mice. The 4.3-kb shbg transgenes were
expressed at similar levels in liver and kidney, but the abundance of
human shbg transcripts in their testes was much lower than
that in shbg11 mice. Primer extension analysis indicated
that transcription starts 60 bp from the translation initiation codon
for SHBG in liver and kidney of shbg11 mice, and that the
shbg transcripts in their testis are derived from a
separate promoter flanking an alternative exon that replaces the exon
containing the translation initiation codon for SHBG or
androgen-binding protein. At the cellular level, the human
shbg transgenes are expressed in clusters of hepatocytes
located mainly within the periportal region of hepatic lobules and in
the epithelial cells lining the proximal convoluted tubules of the
kidney. This results in high levels of human SHBG in serum (1.451.72
nmol/ml) and urine (616 pmol/ml) of mature male shbg
mice. The abundance and distribution of human shbg
transcripts in the Sertoli cells of shbg11 mice vary
throughout the spermatogenic cycle, with levels increasing in the
Sertoli cell cytoplasm until stage VII of spermatogenesis and declining
after stage IX. At stages XXII of spermatogenesis, these transcripts
concentrate at the adluminal compartment of the Sertoli cells, and this
suggests that they have a role in the elongation phase of
spermiogenesis. The presence of human SHBG in the blood of
shbg transgenic mice may result in serum levels of
testosterone that are 10100 times higher than those in wild-type
littermates. Despite this, their reproductive performance is normal,
and there is no obvious phenotypic abnormalities even in animals
homozygous for the transgenes.
 |
INTRODUCTION
|
---|
Sex hormone-binding globulin (SHBG) transports sex steroids in the
blood and regulates their access to target cells (1). Hepatocytes are
probably the major site of plasma SHBG biosynthesis (2), but the SHBG
gene (shbg) is also expressed in the testis (3, 4) and
several other tissues (5, 6, 7). Expression of shbg in the rat
testis gives rise to the androgen-binding protein (ABP), which is
secreted by Sertoli cells into the seminiferous tubules where it is
thought to influence sperm maturation (8). Several differentially
spliced shbg transcripts are also present in human (3, 9)
and rat testis (10) as well as in fetal rat liver and adult rat brain
(10, 11). Their protein products have never been identified or shown to
have any biological function, but one alternative shbg
transcript in rat tissues (10) encodes a protein that is capable of
translocating to the cell nucleus and is also recognized by an
antiserum against rat ABP (12).
In addition to regulating the bioavailability of testosterone and
estradiol, human SHBG interacts with the plasma membranes of several
sex steroid-dependent cells and tissues (13, 14, 15, 16). This appears to
involve the binding of unliganded SHBG to a specific membrane receptor
protein (17), which may promote its cellular internalization (16, 18)
or cause an increase in intracellular cAMP levels when the
membrane-bound SHBG becomes occupied by steroid ligand (19, 20). The
biological consequences of these activities are not known, but they may
enhance the responses of some cells to sex steroids.
Compared with other mammals, rodents are unusual because their livers
do not produce SHBG postnatally, and rat shbg is expressed
in the liver for only a few days during late fetal development (11). As
a result, the amounts of SHBG in the blood of rats and mice are much
lower than those in other species (21, 22). Why rodent livers do not
produce SHBG postnatally and what impact this has on the biological
activities of sex steroids are questions we sought to address by
producing mice expressing human shbg transgenes. We also
wished to define the transcription units responsible for
shbg expression in different tissues and to develop an
animal model for assessing the relative abundance and biological
significance of its various gene products. To accomplish this, we have
introduced two different portions of the human shbg locus
into the mouse genome by a conventional transgenic approach. One of the
transgenes comprises the eight exons that encode SHBG and only
0.9
kilobase (kb) of 5'-flanking DNA, and the other contains an additional
5 kb of 5'-flanking DNA that includes sequences found in several
alternative shbg transcripts identified from a human testis
complementary DNA (cDNA) library (3). In addition to revealing the
requirements for shbg expression in different cell types, it
was anticipated that the presence of human SHBG in these transgenic
mice might cause an imbalance of androgen and estrogen bioavailability
and affect the growth and function of sex steroid-dependent
tissues.
 |
RESULTS
|
---|
Analysis of Human shbg Transgenic Mice
Two founder animals were used to establish lines for each of the
two human shbg fragments injected into mouse embryos, and a
Southern blot of DNA from their progeny is shown in Fig. 1B
. The shbg11-a line was
derived from a founder in which two separate integrations segregated in
the F1 generation, but only one of these lines was maintained for
further analysis. Lines shbg11-b and shbg4-a were
derived from separate founder animals. Lines shbg4-b and
shbg4-c were derived from a single founder animal and were
maintained as separate lines.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 1. Human shbg Transgenes and
Identification of Transgenic Mice
A, Partial restriction maps of the human shbg genomic
DNA fragments, shbg11 and shbg4, used for
microinjection of one-cell mouse embryos. Both fragments contained the
entire coding region for human SHBG (exons 18) and different amounts
of 5'- and 3'-flanking sequences. The shbg11 also
contained sequences for alternative exons (*) that replace exon 1 in
human testicular cDNAs (3). B, Southern blot representing the genotypes
of the five different human shbg transgenic mouse lines.
Human shbg sequences were identified among
EcoRI-digested genomic DNA using a cDNA probe encoding
human shbg exons 68. Wild-type (wt) mouse DNA was
analyzed as a control in lane 1. The positions of DNA size markers are
shown on the left.
|
|
The number and sizes of EcoRI restriction fragments that
hybridized with the SHBG cDNA (Fig. 1B
) indicate that the transgenes
integrated as head to tail multimers in shbg11-a,
shbg11-b, and shbg4-a mice. The estimated
transgene copy numbers in these lines are 6, 6, and 11, respectively.
Southern blots (Fig. 1B
and data not shown) indicate that three copies
of the transgene are present in shbg4-b mice and that two of
them integrated in a head to head orientation. In shbg4-c
mice, there also appears to be one head to head integration of the
transgene, and the intensity of signals obtained on the Southern blot
(Fig. 1B
) indicates that this line contains eight copies of the
transgene.
Tissue Distribution of Human SHBG mRNA in Transgenic Mice
A Northern blot of RNA extracted from shbg transgenic
and wild-type mouse tissues is shown in Fig. 2
. Samples of spleen RNA were included as
negative controls, and the absence of a signal in wild-type tissues
indicates that endogenous murine shbg transcripts are not
recognized by the human SHBG cDNA. A signal that corresponds to SHBG
mRNA was found in the livers of male mice from each transgenic line,
but the relative abundance of SHBG mRNA in the livers of these animals
varied. A similarly sized (1.8 kb) shbg transcript was found
in the kidneys of mice from four of the five transgenic lines. Its
absence in the kidney of shbg4-b mice was confirmed by
overexposing the blot and by analyzing kidney RNA from other animals in
this line (data not shown). Although a transcript of similar size to
SHBG mRNA in liver was clearly detectable in the testis of both lines
of mice carrying the 11-kb shbg transgene (Fig. 2
), it could
only be seen in the testicular RNA extracts from shbg4-a and
shbg4-c mice after prolonged exposure of the Northern blot
(not shown).

View larger version (39K):
[in this window]
[in a new window]
|
Figure 2. Northern Blot of Human shbg
Transcripts in Transgenic Mouse Tissues
Total RNA from male transgenic (five independent lines shown in Fig. 1 )
and wild-type (wt) mouse spleen (lanes 12), liver (lanes 38),
testis (lanes 914), and kidney (lanes 1520) was subjected to
formaldehyde/agarose gel electrophoresis and blotted onto a nylon
membrane. Human shbg transcripts were detected using a
SHBG 3'-cDNA probe (exons 68), and RNA loading and transfer were
controlled by reprobing with a cDNA encoding mouse 18S ribosomal RNA.
|
|
To further characterize the shbg transcripts in the testis,
a Northern blot of poly(A)+RNA from several
shbg11-b mouse tissues was prepared and first hybridized
with a cDNA for shbg exon 1 sequences, which span the
translation initiation codon for the SHBG precursor polypeptide, and
then rehybridized with a cDNA that corresponds to sequences encoded by
shbg exons 68. Despite the obvious presence of ß-actin
transcripts in testis and brain, the shbg exon 1-specific
probe failed to hybridize with any transcripts in these tissues (Fig. 3
). By contrast, the SHBG cDNA for exons
68 hybridized with a transcript in the testis that is similar in size
to the SHBG mRNA (defined by the presence of exon 1 sequences) in the
liver and kidney, but failed to detect any shbg transcripts
in whole brain polyadenylated [poly(A)+] RNA extracts.
This provided the first indication that the shbg transcripts
in the testes of shbg11 mice originate from a transcription
start site different from that used in the liver and kidney and
comprise an alternative exon 1 sequence.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 3. Relative Abundance of Exon 1-Specific Sequences in
shbg Transcripts Extracted from Different Transgenic
Mouse Tissues
Poly(A)+ RNA (0.52.5 µg) from shbg11-b
mouse tissues was subjected to formaldehyde/agarose gel electrophoresis
and transferred to a nylon membrane. The RNAs on the Northern blot were
hybridized sequentially with human shbg exon 1 and SHBG
3'-cDNA (exons 68) probes. Mouse ß-actin was used to demonstrate
the presence and integrity of mRNA in extracts from different
tissues.
|
|
Mapping the Tissue-Specific shbg Transcription Start
Sites
To map the shbg transcription start sites in
shbg11 transgenic mouse tissues, primer extension of
poly(A)+ RNA from shbg11-b mouse liver, kidney,
and testis was performed using an oligonucleotide complementary to a
region in exon 1 spanning the translation initiation codon for the SHBG
precursor (Fig. 4
). Poly(A)+
RNA from the brain and spleen of transgenic mice was used as a control,
and poly(A)+ RNA from corresponding wild-type mouse tissues
was analyzed in parallel to confirm that primer extension products
originate from human shbg transcripts rather than from
endogenous mouse shbg transcripts. In this experiment,
primer extension products were obtained only with mRNA from the liver
and kidney of transgenic mice (Fig. 4
). These products were all the
same size, and the most abundant product (69 nucleotides) places the
major transcription start site 60 bp 5' from the translation initiation
codon in exon 1 (3).

View larger version (68K):
[in this window]
[in a new window]
|
Figure 4. Mapping the Human shbg Transcription
Start Site in Transgenic Mouse Tissues by Primer Extension Analysis
Poly(A)+ RNA (2.5 µg) from wild-type (wt; lanes 1, 3, 5,
7, and 9) and shbg11-b (lanes 2, 4, 6, 8, and 10) mouse
tissues was hybridized with a 32P-labeled human
shbg exon 1 oligomer and primer-extended with
Superscript reverse transcriptase. The products were analyzed by PAGE
and autoradiography. The sizes of the major extension products
(inclusive of the primer) were determined from a DNA sequencing ladder
and are indicated beside the arrowheads.
|
|
The absence of a primer extension product from the testicular mRNA of
the transgenic mice provides additional evidence that the
shbg transcript in this tissue lacks this exon 1 sequence.
This was confirmed by an additional primer extension experiment (Fig. 5
) in which testicular mRNA from
wild-type and shbg11-a transgenic mice was tested with the
same exon 1-specific primer (lanes 3 and 4) as well as with an exon
2-specific primer (lanes 5 and 6). Primer extension of actin mRNA was
also used as a control, and this gave an appropriately sized major
product (109 nucleotides) of similar abundance from both wild-type and
transgenic mouse testicular mRNA extracts (lanes 1 and 2). Again, no
specific primer extension products were observed from the transgenic
testicular mRNA extracts when the exon 1-specific primer was used (lane
4). By contrast, multiple primer extension products between 210235
nucleotides in length were observed from the same mRNA when an exon
2-specific primer was used (lane 6), and these products were not
obtained in a parallel reaction in which wild-type mouse testicular
poly(A)+ RNA was used as the template (lane 5). The lengths
of these products indicate that the size(s) of the alternative exon 1,
which is used in the testis of shbg11-a (data not shown) and
shbg11-b (Fig. 5
) mice, would be between 161186 bp.

View larger version (66K):
[in this window]
[in a new window]
|
Figure 5. Utilization of Alternative Human
shbg Transcription Start Sites in Transgenic Mouse
Testis
Poly(A)+ RNA from shbg11-a transgenic and
wild-type (wt) mouse testes was hybridized with 32P-labeled
actin or human shbg exon 1 or exon 2
oligomers, and primer-extended with Superscript reverse transcriptase.
The products were analyzed by PAGE and autoradiography. The sizes of
the major extension products (inclusive of the primer) were determined
from a DNA sequencing ladder and are indicated beside the
arrowheads.
|
|
Cellular Localization of SHBG and shbg Transcripts in
Transgenic Mice
The hepatocytes of a shbg11-a male mouse contain
immunoreactive SHBG and SHBG mRNA (Fig. 6
, A and B,
respectively). Furthermore, the relative amounts of SHBG and its mRNA
were generally higher in the cytoplasm of hepatocytes in the periportal
zones of the hepatic lobules compared with those located near the
central veins. Similar results were obtained when a liver from a
shbg4-a mouse was analyzed, whereas livers from wild-type
mice contained no immunoreactive SHBG or SHBG mRNA (data not shown). In
serial sections of a shbg11-a male mouse kidney,
immunoreactive SHBG and SHBG mRNA were both confined to the cytoplasm
of epithelial cells lining the proximal convoluted tubules (Fig. 6
, C
and D, respectively), with the most intense staining of immunoreactive
SHBG seen at the luminal aspect of the cells (Fig. 6C
). Immunoreactive
SHBG and its mRNA also colocalized to these same cells in the kidneys
of shbg4-a mice, but were undetectable in kidneys of
wild-type mice or transgenic mice (shbg4-b) that do not
express the 4.3-kb shbg transgene in the kidney (data not
shown).

View larger version (101K):
[in this window]
[in a new window]
|
Figure 6. Cellular Localization of Human SHBG and
shbg Transcripts in the Liver, Kidney, and Testis of
Mature Male Transgenic Mice Brightfield micrographs show the cellular
localization of immunoreactive human SHBG (A, C, E, and G) and human
shbg transcripts using DIG-labeled SHBG antisense
riboprobes (B and D), and the darkfield micrographs (monochrome
threshold image) are mouse testes sections probed for
shbg transcripts with an 35S-labeled SHBG
antisense riboprobe (F and H). Serial cross-sections of a hepatic
lobule from a 65-day-old shbg11-a mouse liver
illustrating the presence of human SHBG (A) and its mRNA (B) in the
same hepatocyte populations. Central (cv) and portal (pv) veins are
shown, with arrows indicating the periportal regions of
a hepatic lobule. Serial longitudinal sections of the S2 segment (inner
zone of the cortex) of a 43-day-old shbg11-a mouse
kidney showing immunoreactive human SHBG (C) and its mRNA (D) in the
same epithelial cells lining the proximal convoluted tubules. The most
intense immunoreactivity was present at the luminal aspects of these
cells (D). The position of a glomerulus (g) is marked. Cross-sections
of testes from shbg11 (E and F) and shbg4
(G and H) mice. Immunoreactive human SHBG is most abundant at the
boundary tissue of the seminiferous tubules and in interstitial
compartments of testes taken from 54-day-old shbg11-b
(E) and 42-day-old shbg4-a (G) mice, but can also be
detected (arrows) in a few Sertoli cells (G). A
monochrome threshold image (F) shows the intensity of silver grains
that mark the shbg transcripts in a 43-day-old
shbg11-a mouse testis, which are distributed uniformly
throughout the Sertoli cells of seminiferous tubules at stages VII and
VIII and are concentrated in the adluminal region of the Sertoli cells
at stages XXII of spermatogenesis. No signals marking
shbg transcripts could be detected in the Sertoli cells
of a 42-day-old shbg4-a mouse testis (H).
Bar = 100 µm.
|
|
Most of the immunoreactive SHBG was restricted to the interstitial
compartment of testes from both shbg11-b and
shbg4-a mice (Fig. 6
, E and G), but it could also be
detected in a few Sertoli cells (Fig. 6G
). The most intense
immunostaining was associated with the boundary tissue of the
seminiferous tubules as well as the interstitial fluid surrounding
Leydig cells that contain no immunoreactive SHBG. By contrast,
shbg transcripts could only be detected in testes of
shbg11-a (Fig. 6F
) and shbg11-b (not shown) mice,
and their abundance in the Sertoli cells of individual seminiferous
tubules differed remarkably. We, therefore, compared the abundance of
shbg transcripts in the Sertoli cells of these mice with the
stage of spermatogenesis in individual seminiferous tubules (Fig. 7
). This demonstrated that expression of
the 11-kb shbg transgene in the testis varies in a
stage-specific manner throughout the spermatogenic cycle, with low
levels of transcripts in the seminiferous tubules at stages IIII
followed by a progressive increase until stage VII. Although the
abundance of these transcripts in the Sertoli cells declines steadily
after stage IX, they invariably accumulate in the adluminal regions of
these cells at stages XXII of spermatogenesis (Fig. 6F
). This
apparent cellular partitioning of the shbg transcripts was
quite striking and was very distinct from their relatively uniform
distribution in Sertoli cells at stages VVIII of the spermatogenic
cycle.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 7. Quantitative in situ Hybridization
of shbg Transcripts in the Seminiferous Tubules of a
43-day-old shbg11-a Mouse Testis with Respect to the Stage of
Spermatogenesis
Relative abundance of human shbg transcripts (pixel gray
values/seminiferous tubule) in Sertoli cells plotted with respect to
the stage of spermatogenesis. The intensity of signals is obtained by
measuring the pixel gray values on a monochrome threshold image
(Northern Eclipse Image Analysis Software) in the Sertoli cells of
individual seminiferous tubules, and each measurement was divided by
the area of the seminiferous tubule excluding the lumen. Values are the
mean (columns) ± SD (bars)
for at least four seminiferous tubules per stage (IXII) of the
spermatogenic cycle.
|
|
Human SHBG in the Urine of Transgenic Mice
The presence of shbg transcripts in the epithelial
cells lining the proximal convoluted tubules of the kidney and the
accumulation of immunoreactive human SHBG at their luminal surface
(Fig. 6C
) suggest that SHBG is produced by these cells and is secreted
into the renal tubules. We, therefore, assessed the amount and
integrity of SHBG in the urine of male mice that either express
(shbg4-a) or do not express (shbg4-b) the 4.3-kb
shbg transgene in the kidney. When a Western blot was used
to detect human SHBG in serum and urine samples from these transgenic
mice and control wild-type mice (Fig. 8
),
immunoreactive SHBG was only found in the urine of mice that express
the transgene in the kidney. The SHBG in the urine of these animals
exhibited the typical heavy (
50-kDa) and light (
48-kDa)
protomeric isoforms seen in human (23) and transgenic mouse serum
samples (Fig. 8
, lane 3), and the fact that it can be quantified by a
steroid binding capacity assay (6 pmol/ml) indicates that it has a
functional steroid-binding site. The amounts of SHBG in the urine of
male shbg4-a (n = 3) and shbg11-a
mice were also very similar (616 pmol/ml).

View larger version (53K):
[in this window]
[in a new window]
|
Figure 8. Western Blot of Human SHBG in the Transgenic Mouse
Serum and Urine
Serum (1:500 in PBS) and urine samples from wild-type (wt) mice and
transgenic mice that either express (shbg4-a) or do not
express (shbg4-b) a human shbg4 transgene
in kidney were subjected to SDS-PAGE and transferred to a
nitrocellulose membrane for Western blot analysis with an antiserum
specific for human SHBG. The relative positions of protein size markers
are shown on the left.
|
|
Blood Levels of SHBG and Testosterone in shbg
Transgenic Mice
The serum concentrations of SHBG and testosterone in 90-day-old
shbg11-a, shbg4-a and shbg4-c male
mice are presented in Table 1
. These
analyses were performed on serum samples from animals hemizygous for
the transgenes and their wild-type littermates, and illustrate the
variability in serum SHBG levels between lines. Although there is
obviously no clear relationship between SHBG and testosterone levels in
these animals, serum testosterone levels in the transgenic animals are
remarkably high compared with those in wild-type mice, and this was
most evident in the shbg11-a mice (Table 1
).
Phenotype Analysis
The body weights, and testis and kidney weights of mature male
shbg11 and shbg4 transgenic mice were similar to
those in age-matched wild-type mice, and no differences were observed
in their epididymal sperm counts or sperm morphology at the light
microscopic level. Routine histology of male accessory sex organs
revealed no obvious differences between shbg transgenic and
wild-type mice. Male shbg transgenic mice from all five
lines were fertile up to at least 9 months of age. The litter sizes of
all five lines of homozygous shbg transgenic mice were
normal, as were the sex ratios of homozygous shbg transgenic
pups within each litter.
 |
DISCUSSION
|
---|
The introduction of human genomic DNA fragments encoding SHBG into
the mouse genome has allowed us to identify sites of human
shbg expression and to define the transcription units
expressed in different tissues. At least two independent lines of
transgenic mice were generated per DNA sequence, and this was done to
control for inappropriate transcription caused by positional effects at
the transgene integration sites. In most lines, the transgenes
integrated as head to tail multimers, exhibited remarkable consistency
with respect to where they were expressed, and remained stable over
several generations. In one founder male, they did not appear to have
integrated as strictly head to tail multimers, and segregated as two
separate genotypes that were maintained for further comparisons because
one of them lacked expression in the kidney.
The 11- and 4.3-kb human shbg transgenes were expressed most
abundantly in the mouse liver and kidney and to a lesser extent in the
testis. This pattern of expression is different from that reported for
mature male transgenic mice containing a rat shbg transgene,
in which transcripts that encode SHBG or ABP are essentially confined
to the testis (24, 25). These differences might imply that
gene-specific sequences play a major role in determining
shbg expression in a given tissue, but this is difficult to
reconcile with the fact that rat shbg is expressed in fetal,
but not adult, livers (11). This paradox might, however, be explained
by the specific utilization of an alternative promoter in fetal livers
or the presence of trans-acting factors at specific
developmental stages.
In the liver, the shbg transgenes exhibited some variation
in expression between lines, with the lowest levels of SHBG mRNA
observed in the line (shbg4-b) with only three copies of the
4.3-kb transgene. In the other four lines, this variability was less
pronounced and suggests that the transgenes are essentially unaffected
by differences in their position within the mouse genome, and that the
additional sequences in the 11-kb transgenes exert little effect on the
expression of shbg in this tissue. More importantly, these
results indicate that all of the information required for transcription
of human shbg in the liver is contained within the 4.3-kb
shbg transgene, which comprises only 0.85 kb of 5'-DNA
flanking exon 1 of the human shbg gene. Our primer extension
analysis indicates that human shbg transcription in the
liver initiates 60 bp 5' of the translation initiation codon for SHBG
in exon 1, and when this is compared with the major transcription start
site for ABP mRNA in the rat testis (26), it places the proximal
promoters responsible for shbg transcription in the liver
and testis in a very similar context.
At the cellular level, human SHBG mRNA was confined to hepatocytes in
transgenic mouse livers, and this was expected because the human
hepatoma cell line (HepG2) produces and secretes SHBG (2). However,
immunoreactive SHBG and its mRNA generally colocalized in hepatocyte
clusters within the periportal region of the hepatic lobules, and a
subset of hepatocytes in this location, therefore, appears to be
largely responsible for producing plasma SHBG. This is consistent with
the concept that gene expression in hepatocytes is often influenced by
differentiation events determined by their anatomical location as well
as developmental stage, as reported recently for the mouse
-fetoprotein gene (27).
Both 11- and 4.3-kb shbg transgenes are expressed in the
mouse kidney, and our primer extension experiments indicate that human
shbg is under the control of the same promoter in the liver
and kidney. Immunoreactive SHBG and its mRNA also colocalize in
epithelial cells lining the proximal convoluted tubules, and the SHBG
in these cells appears to concentrate at their luminal surface. This
suggests that SHBG is produced and secreted by these cells into the
renal tubules, and we confirmed this by showing that SHBG is present
only in the urine of mice expressing shbg transgenes in
their kidneys. The shbg4-b mice that express human
shbg in their livers, but not in their kidneys, represent a
perfect control for this experiment and are of particular interest to
us because the transgenes in this line may have lost sequences that act
in concert with the proximal promoter flanking exon 1 to direct the
kidney-specific expression of shbg or may have integrated
adjacent to a host sequence that acts as a tissue-specific
repressor.
The relatively high levels of SHBG mRNA in the kidneys of
shbg transgenic mice were unexpected, even though we were
aware that shbg transcripts have been identified in hamster
kidney (28). Thus, the kidney may represent an important and largely
overlooked site of shbg expression in some species, and the
local production of SHBG in the kidney could influence the activities
of sex steroids within the renal tubules, perturbations of which are
associated with the development of lupus in both mice and humans (29).
We have detected mouse shbg transcripts in kidney RNA
extracts from wild-type mice by Northern blotting (our unpublished
data), and it will therefore be important to determine whether
shbg is also expressed in the adult human kidney, and if it
influences the way sex steroids impact on renal physiology in mice and
humans.
Human and rat shbg transgenes are obviously expressed quite
differently in the mouse testis. In Sertoli cells, the rat transgene
gives rise to appreciable amounts of ABP in the testis and epididymis,
and this is associated with impaired spermatogenesis and infertility
(25). By contrast, we were unable to identify immunoreactive human SHBG
in the seminiferous tubules or epithelial cells of the epididymis from
any of our transgenic mice, and this may explain why their testes
appear to function normally. These differences obviously reflect a much
greater transcriptional activity at the promoter flanking exon 1 of the
rat shbg transgene compared with the human shbg
transgenes in the testis, and this was confirmed by our failure to
detect human shbg transcripts that originate from the
promoter flanking exon 1 in testes of shbg11 mice by primer
extension as well as the very low levels of shbg transcripts
in testes of the mice containing the 4.3-kb transgene.
Why the human and rat shbg transgenes are expressed so
differently in the mouse testis is unclear, but mouse shbg
is also expressed at relatively low levels in the testis compared with
the rat gene (4). One obvious difference between these transgenic mice,
however, is that the concentration of SHBG in the plasma of mice
expressing the human transgenes, as determined by its steroid binding
capacity, is at least 300-fold greater than that in mice expressing the
rat shbg transgene (25) and might influence the
intratesticular bioavailability of testosterone if it gains access to
the interstitial compartment of the testis. This may be relevant
because the expression of the rat shbg gene in the testis is
increased by androgen treatment in vivo (30). It is also
possible that androgens do not exert this effect directly and function
through an intermediary androgen-responsive paracrine factor produced
by peritubular cells, which, in turn, influences the transcriptional
control of ABP production in Sertoli cells. In support of this, the
interstitial lymphatic spaces of all shbg transgenic mouse
testes contained appreciable amounts of immunoreactive SHBG. The most
intense staining was observed in the vicinity of blood vessels of the
perfused-fixed testes, and this supports our assumption that the SHBG
in the interstitial compartment of the testes is largely derived from
the blood circulation. In addition to being distributed throughout the
interstitial lymphatic space and surrounding the Leydig cells,
immunoreactive SHBG appeared to concentrate in the boundary tissue of
the seminiferous tubules, and this is consistent with the idea that it
might restrict testosterone bioavailability at this location. However,
any effect this may have on testicular function must be subtle and
certainly does not compromise the reproductive performance of these
animals.
Although shbg transcripts in shbg4 mouse testes
most likely comprise the exon 1 sequences that encode the signal
polypeptide required for plasma SHBG or testicular ABP secretion (3),
this exon appears to be replaced by an alternative sequence in the
majority of testicular transcripts that originate from the 11-kb
shbg transgene. The observation that the alternative human
shbg transcripts predominate in the testes of transgenic
mice is intriguing and raises the question of how abundant they might
be in the human testis. This is an important issue because although
several cDNAs representing shbg transcripts in human testis
have been identified, none of them comprises exon 1 sequences (3, 9).
The alternative shbg exon 1 sequence in the transcripts
extracted from shbg11 mouse testes is obviously located
within the unique 5'-region of the transgene and is identical (our
unpublished data) to that used in the human testis (3). We do not know
whether these transcripts are translated, but if they are, their
products are not recognized by antiserum against human SHBG. However,
their accumulation in Sertoli cells varies in a spermatogenic
stage-specific manner, and it appears that the transgene is activated
at stages IVV of the spermatogenic cycle and that the resulting
transcripts are most abundant at stages VII and VIII. At stages
IVVIII of the spermatogenic cycle, the shbg transcripts
are distributed uniformly in the Sertoli cell cytoplasm, but after
spermiation they accumulate in the adluminal compartment of these cells
at stages XXII. This is indicative of their possible localization in
the penetrating processes that reside in the cytoplasmic lobules of
step 1012 spermatids. These penetrating processes are involved in the
transfer of cytoplasmic constituents between Sertoli cells and germ
cells (31, 32), and it is possible that shbg transcripts
containing an alternative exon 1 sequence and are transferred to the
germ cell, where they might have some function during the elongation
phase of spermiogenesis. After stage XII of spermatogenesis, there is a
very rapid loss of shbg transcripts in the Sertoli cell
cytoplasm, and residual transcripts remain associated primarily with
step 13 spermatids. During spermatid condensation and spermiation,
shbg transcripts are no longer associated with step 15 and
16 spermatids, and this is consistent with a transient function for
these transcripts in spermatids just before condensation.
Differences in the metabolic clearance of sex steroids in human blood
are related directly to their relative affinities for SHBG and its
plasma concentration (33). The presence of human SHBG in the blood of
the transgenic mice we have produced, therefore, probably accounts for
the extraordinarily high (>1 µM) plasma concentrations
of testosterone in some of these animals compared with those in
wild-type mice. Despite this, their reproductive performance does not
appear to be affected in any way, and we have been able to breed all
five lines of human shbg transgenic mice to homozygosity.
Male mice homozygous for a rat shbg transgene also have ABP
in their blood that presumably originates from the testis (25), but its
plasma concentrations are much lower than those of human SHBG in any of
the transgenic mice we have produced. Furthermore, the plasma levels of
testosterone in rat shbg transgenic mice are not different
from those in wild-type mice (25), and this might be due to the fact
that the affinity of rat ABP for sex steroids is much lower than that
for human SHBG (22). However, mice expressing the rat shbg
transgene not only suffer from impaired fertility, but are also
characterized by a hind limb motor dysfunction (25) that was not
observed in any of the mice expressing human shbg
transgenes. Only one line of rat shbg transgenic mice has
been characterized, and the neuromuscular defect observed in these
animals might be the result of disruption of an endogenous gene during
transgene insertion. This underscores the importance of generating and
characterizing more than one transgenic line.
Although we have focused here on studying the expression of human
shbg transgenes in male mice, their expression in female
mice also results in high concentrations of SHBG and increased sex
steroid hormone levels in their blood (unpublished data). The actual
amounts of nonprotein-bound, or free, sex steroids in these animals is
not known, and will be difficult to determine because the percentage of
free hormone in serum samples will be very much less than 1% in
animals with greater than 1 nM SHBG in their blood. It is
remarkable, however, that there is no clear correlation between serum
SHBG and testosterone concentrations in different animals, and this is
most obvious when different lines of mice are compared. For instance,
the concentrations of testosterone are approximately 10-fold lower in
male shbg4-a mice than in male shbg11-a mice of
similar age despite the fact that these animals have very similar serum
levels (
1 µM) of SHBG. The reason for this is unclear,
but this will result in marked differences in the relative amounts of
bioavailable sex steroids in the blood of these different lines.
Mice homozygous for human shbg transgenes are fertile, and
the litter sizes and sex ratios of their progeny are within normal
limits. Despite the extraordinarily high serum testosterone levels in
some of the male shbg transgenic mice, we have not observed
any obvious phenotypic differences in these animals to date, but it is
possible that abnormalities in sex steroid-sensitive tissues will
become evident as the animals age. However, the expression of human
shbg transgenes in mice has already provided us with some
insight into the tissue-specific expression of this gene in
vivo, and these animals now represent a model system for
dissecting the molecular basis for its regulation in different tissues
during development and after treatment with various hormones.
 |
MATERIALS AND METHODS
|
---|
Animals
Mice were obtained from in-house breeding stocks and housed in a
pathogen-free facility. The one-cell embryos for microinjections were
obtained by superovulating CBA x C57BL6 hybrid females with
pregnant mare serum and hCG (Sigma Chemical Co. Mississauga, Canada)
and mating them with CBA x C57BL6 males (34). The same hybrid
cross was used to propagate transgenic mouse lines. Female CD-1 mice
were used to produce pseudopregnant recipients by mating with
vasectomized CD-1 males.
Production of Transgenic Mice
An 11-kb HindIII fragment comprising all eight exons
that encode SHBG together with
6 and 2 kb of 5'- and 3'-flanking
sequences, respectively (Fig. 1
), was excised from a human
shbg cosmid clone (3) and subcloned into pBluescript
(Stratagene, La Jolla, CA). This genomic fragment includes sequences
that contribute to shbg transcripts found in human testis
(Fig. 1A
) and are located 1.5 kb 5' to the exon (exon 1) containing the
initiation codon for the SHBG precursor polypeptide (3). Digestion of
the 11-kb shbg HindIII fragment with XhoI
releases a 4.3-kb portion of human shbg that also comprises
all eight exons encoding SHBG plus 0.9 kb 5' of the translation
initiation codon in exon 1 and 0.5 kb 3' from the polyadenylation
sequence in exon 8 (Fig. 1A
).
The pBluescript containing the 11-kb shbg sequence was
purified using a Qiagen Tip-500 column (Qiagen, Chatsworth, CA), and
the shbg fragments obtained by HindIII (11 kb)
and XhoI (4.3 kb) digestion were purified twice by agarose
gel electrophoresis and electroelution. They were then passed through
an Elutip-D column (Schleicher and Schuell, Keene, NH) before
microinjection into the pronuclei of one-cell mouse embryos (34).
Injected embryos were implanted into pseudopregnant recipient mice
using a standard protocol (34) approved by the animal care committee of
the University of Western Ontario.
Founder Identification and Transgene Analysis
Genomic DNA (5 µg) from tail biopsies was digested with
EcoRI and subjected to agarose gel electrophoresis (34). The
DNA fragments in the gel were transferred to a ZetaProbe (Bio-Rad,
Mississauga, Canada) nylon membrane and subsequently hybridized with a
32P-labeled SHBG cDNA (3'-EcoRI fragment) that
recognizes exons 68 of human shbg (3, 35). The blotting,
hybridization, and washing conditions were recommended by Bio-Rad.
Radioactivity on the blots was detected by exposure to x-ray film
(DuPont Canada, Mississauga, Canada) against an intensifying
screen.
Tissue RNA Analysis
TRIzol reagent (Life Technologies, Burlington, Canada) was used
to extract RNA from mouse tissues, and poly(A)+ RNA was
isolated using a PolyATtract mRNA Isolation System IV (Promega,
Madison, WI). Total RNA (
10 µg) or poly(A)+ RNA
(0.52.5 µg) was electophoresed in a formaldehyde/agarose gel and
transferred to a ZetaProbe nylon membrane, as recommended by Bio-Rad.
The RNA was first hybridized with 32P-labeled human SHBG
cDNA (3' EcoRI fragment). After washing at high stringency
and exposure to x-ray film to detect shbg transcripts, the
hybridized SHBG cDNA probe was stripped from the blot, which was then
rehybridized with a cDNA of mouse 18S ribosomal RNA as a loading and
transfer control. A Northern blot of poly(A)+ RNAs was
first hybridized with a 32P-labeled
SmaI-ApaI fragment of human shbg that
contains a 183-bp sequence within exon 1 spanning the translation start
site (3). After detection on an x-ray film, the radioactive probe was
stripped from the blot for sequential rehybridization with a human SHBG
cDNA (3'-EcoRI fragment) and a mouse ß-actin cDNA.
Primer Extension of shbg Transcripts
Poly(A)+ RNA (2.5 µg) from shbg11 and
wild-type mouse tissues was hybridized with a 32P-labeled
oligonucleotide complementary to human shbg exon 1
(5'-GCTCTCCATAATCAGCCACTGTCC-3') or exon 2
(5'-CTTGTCCTGGGCCATTGCTGAGGTG-3') sequences, and primer extended with
Superscript reverse transcriptase (Life Technologies) using a standard
method (36). A 32P-labeled oligonucleotide
(5'-ACCAGCGCAGCGATAATCGCCATCCAT-3') that recognizes mouse actin mRNA
(37) was also used as a control. The primer-extended products were
analyzed by electrophoresis on an 8% acrylamide DNA sequencing gel and
autoradiography, and their sizes were determined by comparison with the
products of a DNA sequencing reaction.
Immunohistochemistry
Tissues were fixed in situ by transcardial perfusion
of anesthetized animals with ice-cold Bouins fluid or 70
mM phosphate buffer, pH 7.0, containing 4%
paraformaldehyde, followed by immersion in the same fixatives at 4 C
for 20 h. Tissues were also removed and immersed directly in these
fixatives for routine histology. Fixed tissues were embedded in
paraffin wax, and 5-µm thick sections were cut and mounted onto
SuperFrost-coated slides (VWR, Westchester, PA). After dewaxing and
rehydration, tissue sections were incubated sequentially in 0.3%
hydrogen peroxide to quench endogenous peroxidase activity, in 0.1%
trypsin for 10 min, and then in nonimmune serum for 20 min. They were
then incubated with diluted (1:500 to 1:2000) rabbit antihuman SHBG
antiserum (38) at 4 C for 16 h. After washing in PBS, antibody
complexes were detected by incubation with a biotinylated secondary
antibody and the avidin-biotin-peroxidase complex (Vectastain, Vector
Laboratories, Burlingame, CA) with 3,3'-diaminobenzidine tetrachloride
as the chromagen. Slides were counterstained with Harriss hematoxylin
and mounted with Permount (Fisher Scientific, Unionville, Canada).
In Situ Hybridization
Sense and antisense human SHBG riboprobes were transcribed in
the presence of digoxigenin-11-UTP (Boehringer Mannheim, Laval, Canada)
or [35S]UTP (DuPont Canada, Mississauga, Canada) from a
0.7-kb 5'-EcoRI fragment of a human SHBG cDNA in a
pT3/T7mp18 vector (35) using commercially available reagents
(Promega).
For hybridization with digoxigenin (DIG)-labeled riboprobes,
rehydrated tissue sections were first treated sequentially with 0.2
M HCl and PBS containing 0.2% Triton-X 100, and then
incubated with 40 µg proteinase K/ml PBS at room temperature for 10
min, followed by a wash in PBS. After a postfixation in PBS containing
4% paraformaldehyde for 30 min, sections were washed in PBS and
treated with 0.1 M triethanolamine containing 2.6
mM acetic anhydride at room temperature for 10 min.
Sections were then dehydrated through ascending ethanols (70100%)
and air-dried.
Before hybridization with DIG-labeled riboprobes, sections were
prehybridized in the presence of 50% formamide in 2 x SSC
(1 x = 0.15 M NaCl and 0.015 M sodium
citrate) at 42 C for 2 h. Hybridization with DIG-labeled
riboprobes was performed at 55 C for 20 h in the presence of 50%
formamide in a buffer containing 2 x SSC, 1 x Denhardts
reagent, 0.4 mg/ml salmon sperm DNA, and 10% dextran sulfate.
Nonhybridized riboprobes were removed by washing in 2 x SSC and
1 x SSC at 50 C, and sections were then incubated with 20 µg
ribonuclease A/ml 10 mM PIPES (pH 7.2), 0.5 M
NaCl, and 0.1% Tween-20 at 37 C for 30 min. After washing in 100
mM Tris-HCl, pH 7.5, and 150 mM NaCl,
hybridized DIG-labeled riboprobes were detected using alkaline
phosphatase-labeled anti-DIG antibody, as recommended by Boehringer
Mannheim. Sections were counterstained with methyl green.
The protocol for in situ hybridization with
35S-labeled riboprobes was described previously (39).
Slides were coated with NTB-2 emulsion (Eastman Kodak, Rochester, NY),
stored for 1 week at 4 C, and developed in D19 developer (Eastman
Kodak). Sections were counterstained with Harriss hematoxylin, and
silver grains were quantified under darkfield illumination using a
Northern Eclipse image analysis system (Empix Imaging, Inc.,
Mississauga, Canada). Serial sections of testes were stained with
periodic acid-Schiffs stain to identify the stages of
spermatogenesis.
Western Blot Analysis
Proteins in mouse urine and diluted serum (1:500 in PBS) were
heat denatured in loading buffer and subjected to discontinuous
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 4% and 10%
polyacrylamide in the stacking and resolving gels, respectively.
Proteins in the gel were transferred electrophoretically (40) to a
Hybond ECL nitrocellulose membrane (Amersham, Mississauga, Canada). The
membrane was preincubated in a 5% skim milk solution and then
incubated overnight at 4 C with rabbit antihuman SHBG antiserum (38)
diluted 1:500 in TBS [10 mM Tris-HCl (pH 7.5), 150
mM NaCl, and 0.05% Tween-20] containing 0.5% skim milk
powder. The blot was then washed several times in TBS to remove excess
antibody, and specific antibody-antigen complexes were identified using
a second antibody (horseradish peroxidase-labeled donkey antirabbit
IgG) and chemiluminescent substrates (Life Technologies) by exposure to
x-ray film.
Serum SHBG and Testosterone Assays
The amounts of SHBG in transgenic mouse serum were determined
using a steroid binding capacity assay (41). In brief, serum samples
were diluted 1:100 in a slurry of dextran-coated charcoal at room
temperature to remove endogenous steroids and then further diluted 1:10
to 1:20 in PBS containing 0.01% gelatin. Aliquots of the diluted serum
samples containing about 0.1 pmol SHBG were incubated (1 h at room
temperature and 30 min at 0 C) with 1 pmol
5
-[3H]dihydrotestosterone (Amersham) in the presence
or absence of a 400-fold molar excess of 5
-dihydrotestosterone to
measure nonspecific binding and total binding, respectively. A
dextran-coated charcoal slurry was then added at 0 C for 10 min to
separate free ligand, and the SHBG-bound fraction was recovered by
centrifugation and decantation of supernatants into scintillation vials
for counting radioactivity. Serum concentrations of SHBG were
determined from the steroid binding capacity measurements after
correction for dilution and assuming one steroid-binding site per mol
SHBG (41). Serum testosterone concentrations were determined by RIA
(Endocrine Sciences, Calabasas Hills, CA).
 |
ACKNOWLEDGMENTS
|
---|
The authors thank Denise Power and Gail Howard for secretarial
assistance.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Geoffrey L. Hammond, Ph.D., Cancer Research Laboratories, London Regional Cancer Center, 790 Commissioners Road East, London, Ontario, Canada N6A 4L6. E-mail:
ghammond{at}julian.uwo.ca
This work was supported by the Medical Research Council of Canada.
Received for publication July 28, 1997.
Revision received September 18, 1997.
Accepted for publication October 16, 1997.
 |
REFERENCES
|
---|
-
Hammond GL 1995 Potential functions of plasma
steroid-binding proteins. Trends Endocrinol Metab 6:298304[CrossRef]
-
Khan MS, Knowles BB, Aden DP, Rosner W 1981 Secretion of
testosterone-estradiol-binding globulin by a human hepatoma-derived
cell line. J Clin Endocrinol Metab 53:448449[Abstract]
-
Hammond GL, Underhill DA, Rykse HM, Smith CL 1989 The human
sex hormone-binding globulin gene contains exons for androgen-binding
protein and two other testicular messenger RNAs. Mol Endocrinol 3:18691876[Abstract]
-
Wang Y, Sullivan PM, Petrusz P, Yarbrough W, Joseph DR 1989 The androgen-binding protein gene is expressed in CD1 mouse testis. Mol
Cell Endocrinol 63:8592[CrossRef][Medline]
-
Wang Y, Bayliss DA, Millhorn DE, Petrusz P, Joseph DR 1990 The androgen-binding protein gene is expressed in male and female
rat brain. Endocrinology 127:31243130[Abstract]
-
Misao R, Itoh N, Mori H, Fujimoto J, Tamaya T 1994 Sex
hormone-binding globulin mRNA levels in human uterine endometrium. Eur
J Endocrinol 131:623629[Medline]
-
Larrea F, Diaz L, Carino C, Larriva-Sahd J, Carrillo L,
Orozco H, Ulloa-Aguirre A 1993 Evidence that human placenta is a site
of sex hormone-binding globulin gene expression. J Steroid Biochem Mol
Biol 46:497505[CrossRef][Medline]
-
Joseph DR 1994 Structure, function, and regulation of
androgen-binding protein/sex hormone-binding globulin. Vitam Horm 49:197280[Medline]
-
Gershagen S, Lundwall A, Fernlund P 1989 Characterization of the human sex hormone binding globulin (SHBG) gene
and demonstration of two transcripts in both liver and testis. Nucleic
Acids Res 17:92459258[Abstract]
-
Sullivan PM, Wang Y, Joseph DR 1993 Identification of an
alternate promoter in the rat androgen-binding protein/sex
hormone-binding globulin gene that regulates synthesis of a messenger
RNA encoding a protein with altered function. Mol Endocrinol 7:702715[Abstract]
-
Sullivan PM, Petrusz P, Szpirer C, Joseph DR 1991 Alternative
processing of androgen-binding protein RNA transcripts in fetal liver.
J Biol Chem 266:143154[Abstract/Free Full Text]
-
Joseph DR, Becchis M, Fenstermacher DA, Petrusz P 1996 The alternate N-terminal sequence of rat androgen-binding protein/sex
hormone-binding globulin contains a nuclear targeting signal.
Endocrinology 137:11381143[Abstract]
-
Strelchyonok OA, Avvakumov GV, Survilo LI 1984 A
recognition system for sex-hormone-binding protein-estradiol
complex in human decidual endometrium plasma membranes. Biochim Biophys
Acta 802:459466[Medline]
-
Hryb DJ, Khan MS, Romas NA, Rosner W 1989 Solubilization and
partial characterization of the sex hormone-binding globulin receptor
from human prostate. J Biol Chem 264:53785383[Abstract/Free Full Text]
-
Fortunati N, Fissore F, Fazzari A, Berta L, Varvello L,
Frairia R 1992 Receptor for sex steroid-binding protein of endometrium
membranes: solubilization, partial characterization, and role of
estradiol in steroid-binding protein-soluble receptor interaction.
Steroids 57:464470[CrossRef][Medline]
-
Porto CS, Musto NA, Bardin CW, Gunsalus GL 1992 Binding of an
extracellular steroid-binding globulin to membranes and soluble
receptors from human breast cancer cells (MCF-7 cells). Endocrinology 130:29312936[Abstract]
-
Hryb DJ, Khan MS, Romas NA, Rosner W 1990 The control of the
interaction of sex hormone-binding globulin with its receptor by
steroid hormones. J Biol Chem 265:60486054[Abstract/Free Full Text]
-
Bordin S, Petra PH 1980 Immunocytochemical localization of the
sex steroid-binding protein of plasma in tissues of the adult monkey
Macaca nemestrina. Proc Natl Acad Sci USA 77:56785682[Abstract]
-
Nakhla AM, Khan MS, Rosner W 1990 Biologically active steroids
activate receptor-bound human sex hormone-binding globulin to cause
LNCaP cells to accumulate adenosine 3',5'-monophosphate. J Clin
Endocrinol Metab 71:398404[Abstract]
-
Fissore F, Fortunati N, Comba A, Fazzari A, Gaidano G, Berta
L, Frairia R 1994 The receptor-mediated action of sex steroid binding
protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and
estradiol treatment. Steroids 59:661667[CrossRef][Medline]
-
Gunsalus GL, Musto NA, Bardin CW 1978 Immunoassay of
androgen binding protein in blood: a new approach for study of the
seminiferous tubule. Science 200:6566[Medline]
-
Westphal U 1986 Steroid-Protein Interactions. II. Monographs
on Endocrinology. Springer-Verlag, Heidelberg
-
Cheng CY, Musto NA, Gunsalus GL, Bardin CW 1983 Demonstration
of heavy and light promoters of human testosterone-estradiol-binding
globulin. J Steroid Biochem 19:13791389[CrossRef][Medline]
-
Reventos J, Sullivan PM, Joseph DR, Gordon JW 1993 Tissue-specific expression of the rat androgen-binding protein/sex
hormone-binding globulin gene in transgenic mice. Mol Cell Endocrinol 96:6973[CrossRef][Medline]
-
Joseph DR, OBrien DA, Sullivan PM, Becchis M, Tsuruta JK,
Petrusz P 1997 Overexpression of androgen-binding protein/sex
hormone-binding globulin in male transgenic mice: tissue distribution
and phenotypic disorders. Biol Reprod 56:2132[Abstract]
-
Joseph DR, Hall SH, Conti M, French FS 1988 The gene structure
of rat androgen-binding protein: identification of potential regulatory
deoxyribonucleic acid elements of a follicle-stimulating
hormone-regulated protein. Mol Endocrinol 2:313[Abstract]
-
Ramesh TM, Ellis AW, Spear BT 1995 Individual mouse
-fetoprotein enhancer elements exhibit different patterns of
tissue-specific and hepatic position-dependent activities. Mol Cell
Biol 15:49474955[Abstract]
-
Damassa DA, Cates JM, Gagin GA, Sex hormone-binding globulin
(SHBG/ABP) expression in the kidney of postnatal and pubertal
djungarian hamsters. 9th International Congress on Hormonal Steroids,
Dallas TX, 1994, B170:-111 (Abstract)
-
Blank M, Mendlovic S, Fricke H, Mozes E, Talal N, Shoenfeld Y 1990 Sex hormone involvement in the induction of experimental systemic
lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice.
J Rheumatol 17:311317[Medline]
-
Reventos J, Hammond GL, Crozat A, Brooks DE, Gunsalus GL,
Bardin CW, Musto NA 1988 Hormonal regulation of rat androgen-binding
protein (ABP) messenger ribonucleic acid and homology of human
testosterone-estradiol-binding globulin and ABP complementary
deoxyribonucleic acids. Mol Endocrinol 2:125132[Abstract]
-
Sakai Y, Nakamoto T, Yamashina S 1988 Dynamic changes in
Sertoli cell processes invading spermatid cytoplasm during mouse
spermiogenesis. Anat Rec 250:5157
-
Segretain D, Degrossas B 1991 The Sertoli-spermatid processes
in the mouse: new cellular structure. Biol Cell 71:321324[CrossRef][Medline]
-
Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn
RW 1982 The serum transport of steroid hormones. Recent Prog Horm Res 38:457510[Medline]
-
Hogan B, Beddington R, Costantini F, Lacy E 1994 Manipulating
the Mouse Embryo: A Laboratory Manual, ed 2. Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY
-
Hammond GL, Underhill DA, Smith CL, Goping IS, Harley MJ,
Musto NA, Cheng CY, Bardin CW 1987 The cDNA-deduced primary structure
of human sex hormone-binding globulin and location of its
steroid-binding domain. FEBS Lett 215:100104[CrossRef][Medline]
-
Chodosh LA 1991 Current Protocols in Molecular Biology.
Current Protocols, New York, pp 12.5.112.5.8
-
Lee H-L, Archer TK 1994 Nucleosome mediated disruption of
transcription factor: chromatin initiation complexes as the mouse
mammary tumor virus long terminal repeat in vivo. Mol Cell
Biol 14:3142
-
Hammond GL, Langley MS, Robinson PA 1985 A liquid-phase
immunoradiometric assay (IRMA) for human sex hormone binding globulin
(SHBG). J Steroid Biochem 23:451460[CrossRef][Medline]
-
Scrocchi LA, Orava M, Smith CL, Han VKM, Hammond GL 1993 Spatial and temporal distribution of corticosteroid-binding globulin
and its messenger ribonucleic acid in embryonic and fetal mice.
Endocrinology 132:903909[Abstract]
-
Towbin H, Staehelin T, Gordon J 1979 Electrophoretic transfer
of proteins from polyacrylamide gels to nitrocellulose sheets:
procedure and some applications. Proc Natl Acad Sci USA 76:43504354[Abstract]
-
Hammond GL, Lähteenmäki PLA 1983 A versatile
method for the determination of serum cortisol binding globulin and sex
hormone binding globulin binding capacities. Clin Chim Acta 132:101110[CrossRef][Medline]